APA (7th ed.) Citation

Ido, A., Moriuchi, A., Numata, M., Murayama, T., Teramukai, S., Marusawa, H., . . . Tsubouchi, H. (2011). Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: A phase I/II clinical trial, following preclinical studies to ensure safety. Journal of translational medicine, 9(1), 55. https://doi.org/10.1186/1479-5876-9-55

Chicago Style (17th ed.) Citation

Ido, Akio, et al. "Safety and Pharmacokinetics of Recombinant Human Hepatocyte Growth Factor (rh-HGF) in Patients with Fulminant Hepatitis: A Phase I/II Clinical Trial, Following Preclinical Studies to Ensure Safety." Journal of Translational Medicine 9, no. 1 (2011): 55. https://doi.org/10.1186/1479-5876-9-55.

MLA (9th ed.) Citation

Ido, Akio, et al. "Safety and Pharmacokinetics of Recombinant Human Hepatocyte Growth Factor (rh-HGF) in Patients with Fulminant Hepatitis: A Phase I/II Clinical Trial, Following Preclinical Studies to Ensure Safety." Journal of Translational Medicine, vol. 9, no. 1, 2011, p. 55, https://doi.org/10.1186/1479-5876-9-55.